Compare · TMO vs TPIC
TMO vs TPIC
Side-by-side comparison of Thermo Fisher Scientific Inc (TMO) and TPI Composites Inc. (TPIC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both TMO and TPIC operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $173.21B, about 415.3x TPIC ($417.0M).
- Over the past year, TMO is up 11.8% and TPIC is down 86.0% - TMO leads by 97.8 points.
- TMO has hit the wire 9 times in the past 4 weeks while TPIC has been quiet.
- Both have 25 recent analyst ratings on file.
- Company
- Thermo Fisher Scientific Inc
- TPI Composites Inc.
- Price
- $479.36+2.79%
- $0.13-48.93%
- Market cap
- $173.21B
- $417.0M
- 1M return
- -2.51%
- -86.44%
- 1Y return
- +11.81%
- -86.01%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NASDAQ
- IPO
- 2016
- News (4w)
- 9
- 0
- Recent ratings
- 25
- 25
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
TPI Composites Inc.
TPI Composites, Inc. manufactures and sells composite wind blades, and related precision molding and assembly systems to original equipment manufacturers (OEMs). The company also provides composite solutions for the transportation industry; and field service inspection and repair services to OEM customers and wind farm owners and operators. It operates in the United States, Asia, Mexico, Europe, the Middle East, Africa, and India. The company was formerly known as LCSI Holding, Inc. and changed its name to TPI Composites, Inc. in 2008. TPI Composites, Inc. was founded in 1968 and is headquartered in Scottsdale, Arizona.
Latest TMO
- President & COO Pettiti Gianluca sold $185,064 worth of shares (400 units at $462.66) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 25,051 units (SEC Form 4)
- Thermo Fisher Scientific to Host Investor Day
- Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Thermo Fisher Scientific Reports First Quarter 2026 Results
- AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages
- Thermo Fisher Scientific Expands Global Biobank Leadership Through Strategic Collaboration with PRECISE-SG100K Singapore to Advance Population-Scale Proteomics
- SEC Form DEFA14A filed by Thermo Fisher Scientific Inc
- SEC Form DEF 14A filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, April 23, 2026
Latest TPIC
- TPI Composites Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- TPI Composites Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Bankruptcy or Receivership, Events That Accelerate or Increase a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- TPI Composites, Inc. Advances Chapter 11 Process with Court Approval of First-Day Motions
- SEC Form 10-Q filed by TPI Composites Inc.
- TPI Composites Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- TPI Composites, Inc. Initiates Voluntary Chapter 11 Proceedings to Facilitate Restructuring to Position Company for Long-Term Success
- Amendment: SEC Form SCHEDULE 13G/A filed by TPI Composites Inc.
- TPI Composites downgraded by TD Cowen with a new price target
- TPI Composites Inc. filed SEC Form 8-K: Leadership Update
- TPI Composites Inc. filed SEC Form 8-K: Other Events